EP3400947
MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.2.2014EP published:
23.8.2023EP application number:
18179911.5
EPO information:
European Patent Register
Max expiry date:
13.2.2034
Title in English:
MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONSLanguage of the patent:
English
Timeline
Today
14.2.2014EP application
23.8.2023EP Publication
Owner
Name:
Ionis Pharmaceuticals, Inc.Address:
2855 Gazelle Court, Carlsbad, CA 92010, US
Inventor
Name:
ALEXANDER, Veronica J.Address:
Carlsbad, CA 92010, US
Name:
VINEY, Nicholas J.Address:
Carlsbad, CA 92010, US
Name:
WITZTUM, Joseph L.Address:
San Diego, CA 92120, US
Priority
Number:
201361764969 PDate:
14.2.2013Country:
US
Number:
201361880779 PDate:
20.9.2013Country:
US
Classification
Categories:
A61K 31/7088, C12N 15/113